Pharmacokinetic Study of Albuvirtide and Lopinavir/Ritonavir in HIV-infected Patients

Trial Profile

Pharmacokinetic Study of Albuvirtide and Lopinavir/Ritonavir in HIV-infected Patients

Completed
Phase of Trial: Phase I/II

Latest Information Update: 24 Apr 2016

At a glance

  • Drugs Albuvirtide (Primary) ; Lopinavir/ritonavir
  • Indications HIV infections
  • Focus Pharmacokinetics
  • Sponsors Frontier Biotechnologies
  • Most Recent Events

    • 03 Feb 2014 Status changed from recruiting to completed as reported by the Chinese Clinical Trial Register.
    • 24 Apr 2013 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top